Order Article Reprints

Claudiani S, Mason CC, Milojkovic D, Bianchi A, Pellegrini C, Di Marco A, Fiol CR, Robinson M, Ponnusamy K, Mokretar K, et al. Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis. Cancers. 2021; 13(19):4863. https://doi.org/10.3390/cancers13194863

Claudiani, Simone, Clinton C. Mason, Dragana Milojkovic, Andrea Bianchi, Cristina Pellegrini, Antinisca Di Marco, Carme R. Fiol, Mark Robinson, Kanagaraju Ponnusamy, Katya Mokretar, and et al. 2021. "Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis" Cancers 13, no. 19: 4863. https://doi.org/10.3390/cancers13194863

Claudiani, S., Mason, C. C., Milojkovic, D., Bianchi, A., Pellegrini, C., Di Marco, A., Fiol, C. R., Robinson, M., Ponnusamy, K., Mokretar, K., Chowdhury, A., Albert, M., Reid, A. G., Deininger, M. W., Naresh, K., Apperley, J. F., & Khorashad, J. S. (2021). Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis. Cancers, 13(19), 4863. https://doi.org/10.3390/cancers13194863